Innovate UK awards Sano Genetics £330,000 grant for ALS study
Posted:
Sano has been awarded a £330K grant from @InnovateUK to develop “Light The Way,” a platform for individuals at risk of genetic #ALS. Access to genetic testing, counselling, education, and peer support will be provided at no cost.
Schizophrenia is a psychiatric disorder characterized by altered thinking and emotional patterns, hallucinations, false or irrational beliefs (i.e., delusions), cognitive deficits, and disorganized speech.
Bipolar disorder BD, on the other hand, is marked by extreme mood swings, ranging between periods of…
New joint research program combines UCSF’s advanced clinical and research teams with GE HealthCare’s technical and engineering expertise to develop solutions that directly impact patient care.
Read full article here.
Attendees
Sponsors and Exhibitors
Contact us